Further, the minister had rightly pointed out towards the need of off-loading the burden of continued losses of SOEs by fast track privatization, he added.
Sheikh said that the hospital has the capacity of 1000 beds and in case of any emergency like situation due to the rising number of cases, it would be transformed into Corona hospital.
The IMF will revisit that forecast when it issued a fresh World Economic Outlook in July, IMF spokesman Gerry Rice told reporters at a regular briefing, but gave no further details.
"We're all watching what is happening in India with concern," Rice said. "There will be spillovers ... contingent on how deep and how long the severity of this crisis continues."
Moderna said an initial analysis of a study in adolescents aged 12-17 years showed an efficacy rate of 96% for its vaccine.
The company has also been working on a new version that could extend the time the vaccine can be stored in refrigerator temperatures, making it easier to distribute, especially in lower-income countries.
Renault said it was aiming to raise the average turnover per unit of its Arkana model to 30,000 euros ($36,153), from 15,000 euros at present.
Renault is looking to produce fewer cars and focus on those with higher margins, and this strategy is starting to bear some fruit despite weak overall results.
"The EU is also ready to discuss any proposals that addresses the crisis in an effective and pragmatic manner," she said in a speech to the European University Institute in Florence.
"Chinese vaccine stocks had been spurred recently by news of worsening situations in other countries, such as India," said Wu Tianhao, an analyst at Western Securities.
Shares in SocGen have gained 38.5% since the beginning of the year after a 45% slump in 2020. Its share price has more than doubled since its lowest at 10.77 euros on Sept. 30.
Before Thursday, the largest real-world study of the Pfizer/BioNTec vaccine, also in Israel, was nearly five times smaller, involving 1.2 million people.
But that notion has been fiercely opposed by pharmaceutical giants and their host countries, which insist the patents are not the main roadblocks to scaling up production, and warned the move could hamper innovation.
Tedros clashed repeatedly with former US president Donald Trump, who began withdrawing his country from the WHO before President Joe Biden immediately rescinded the move upon taking office in January.